Medline Inc.

We believe that our facilities are sufficient for our current needs and that, should they be needed, additional facilities will be available to accommodate the expansion of our business.

• Medline Canada, Corporation Canada⁶
• Medline Chile SpA Chile⁶
• Medline Co-Issuer, Inc. Delaware⁶
• Medline Costa Rica Srl Costa Rica⁶
• Medline DME GP, LLC Delaware⁶
• Medline DME TN, LP Delaware⁶
• Medline DME, LP Delaware⁶
• Medline Healthcare Industries Private Limited India⁶
• Medline Holdings, LP Delaware⁶
• Medline Hong Kong Limited Hong Kong⁶
• Medline Industries Asia Pte. Ltd. Singapore⁶
• Medline Industries Holdings, L.P. Delaware⁶
• Medline Industries Inc. FZCO United Arab Emirates⁶
• Medline Industries India Private Limited India⁶
• Medline Industries Limited United Kingdom⁶
• Medline Industries Malaysia SDN BHD Malaysia⁶
• Medline Industries Singapore Pte. Ltd. Singapore⁶
• Medline Industries, LP Illinois⁶
• Medline Industries, LP (Shanghai) Ltd. China⁶
• Medline Intermediate, LP Delaware⁶
• Medline International B.V. Netherlands⁶
• Medline International Belgium B.V. Belgium⁶
• Medline International CZ s.r.o. Czech Republic⁶
• Medline International Capital B.V. Netherlands⁶
• Medline International Colombia S.A.S. Colombia⁶
• Medline International France SAS France⁶
• Medline International Germany GmbH Germany⁶
• Medline International Holdco, Inc. Delaware⁶
• Medline International Iberia S.L. Spain⁶
• Medline International Italy S.r.l Italy⁶
• Medline International Netherlands BV Netherlands⁶
• Medline International New Zealand Limited New Zealand⁶
• Medline International Portugal, Unipessoal Lda. Portugal⁶
• Medline International Switzerland Sarl Switzerland⁶
• Medline International Two Australia Pty Ltd. Australia⁶
• Medline International Two, LLC Illinois⁶
• Medline International, LLC Illinois⁶
• Medline Ireland Limited Ireland⁶
• Medline Japan G.K. Japan⁶
• Medline Korea, LLC South Korea⁶
• Medline Logistics Japan G.K. Japan⁶
• Medline Mexico Holdings, LLC Illinois⁶
• Medline Mexico S de RL de CV Mexico⁶
• Medline Mills Industries LLC Illinois⁶
• Medline Operations France SAS France⁶
• Medline Operations Germany GmbH Germany⁶
• Medline Operations Italy S.r.l. Italy⁶
• Medline Operations Ltd. United Kingdom⁶
• Medline Panama Administration LLC S. de R.L. Panama⁶
• Medline Panama LLC S. de R.L. Panama⁶
• Medline Panama Sales LLC S. de R.L. Panama⁶
• Medline Pharmacy LLC Illinois⁶
• Medline Puerto Rico, LLC Puerto Rico⁶
• Medline Real Estate Germany GmbH & Co. KG Germany⁶
• Medline Regional Headquarters Company Saudi Arabia⁶
• Medline SI, Trgovina D.O.O. Slovenia⁶
• Medline Services France SAS France⁶
• Medline Services Switzerland Sarl Switzerland⁶
• Medline Services UK Limited United Kingdom⁶
• Medline Slovakia s.r.o. Slovakia⁶
• Medline Soluciones Medicas Holdings, LLC Illinois⁶
• Medline Soluciones Medicas, S de RL de CV Mexico⁶
• Medline Sooner Acquisition, LLC Illinois⁶
• Medline South Africa (PTY) Ltd. South Africa⁶
• Medline Stellar Australia Pty Ltd. Australia⁶
• Medline Stellar Germany GmbH Germany⁶
• Medline Stellar Italy S.r.l. Italy⁶
• Medline Stellar UK Limited United Kingdom⁶
• Medline Supply Solutions Pty Ltd. Australia⁶
• Medline Sweden AB Sweden⁶
• Medline United Kingdom LLC Illinois⁶
• Medline Ventures, LLC Illinois⁶
• Medline Vietnam Trading Company Limited Vietnam⁶
• Mexicali Directo AL Cliente S de RL de CV Mexico⁶
• Mexicali Directo Holdings, LLC Illinois⁶
• Microtek Dominicana Holdings, LLC Delaware⁶
• Microtek Dominicana, S.A.S. Dominican Republic⁶
• Microtek Medical B.V. Netherlands⁶
• Microtek Medical LLC Delaware⁶
• Microtek Medical Malta Limited Malta⁶
• Mozart GP, LLC Delaware⁶
• Northpoint Medical Processing, LLC Illinois⁶
• Nuevo Laredo Directo Al Cliente S. de R.L. de C.V. Mexico⁶
• PDM Holdings, LLC Illinois⁶
• PMM Holdings, LLC Illinois⁶
• PluroGen Therapeutics, LLC Delaware⁶
• PrefConnect, LLC Texas⁶
• Productos Medline Mexicali S de RL de CV Mexico⁶
• Productos Medline SA de CV Mexico⁶
• RCI Hudson Mexico Holdings, LLC Illinois⁶
• RCI Hudson de Mexico S de RL de CV Mexico⁶
• Simcon International LLC Illinois⁶
• Stellar Holdco, LLC Delaware⁶
• Surgical Instrument Services and Savings, LLC Nevada⁶
• Suture Express, LLC Kansas⁶
• TCS Nuevo Laredo, LLC Delaware⁶
• Thin Candied Shell, LLC Illinois⁶
• Thin Candy Shell, LLC Michigan⁶
• Tri-State Mexico Holdings, LLC Illinois⁶
• Tri-State de Mexico S de RL de CV Mexico⁶
• United Medco, LLC Florida⁶

• We may not realize the expected benefits from the entry into new or amended contracts, planned cost savings, and business improvement initiatives.
• Quality problems and product liability claims have in the past led, and could in the future lead, to recalls or safety alerts, reputational harm, adverse verdicts, or costly settlements, and could have a material adverse effect on our business, results of operations, and financial condition.
• Our failure to establish and maintain Prime Vendor relationships may cause our revenue to decline.
• If we experience increased pressure to maintain or decrease the price of our goods and services and we are unable to reduce our expenses, there may be a material adverse effect on our business, results of operations, and financial condition.
• Any failure by or loss of a third-party manufacturer or supplier or other manufacturing or supply-related impacts could result in delays and increased costs, which may adversely affect our business.
• Risks Related to Regulation and Legal Proceedings
• We rely on the proper function, security, and availability of our information technology systems and data, as well as those of third parties throughout our global supply chain, to operate our business.
• We are subject to extensive and complex laws and governmental regulations and any adverse regulatory action may materially adversely affect our business, results of operations, and financial condition both inside and outside the United States.
• We are subject to extensive environmental, health, and safety requirements, and our operations involve hazardous and other environmentally sensitive substances.
• The failure to comply with anti-corruption laws or trade restrictions, including economic sanctions, could materially adversely affect our business, results of operations, and financial condition and result in civil and/or criminal penalties.
• We are subject to complex and rapidly evolving data privacy, security, and data protection laws and regulations and the costs to comply with such laws and regulations or any ineffective compliance efforts with such laws and regulations may adversely impact our business.
• Our use or our third-party service providers’ or business partners’ use of AI, automated decision-making and machine learning technologies and the evolving regulatory framework in this area may subject us to risks or heightened costs that could adversely affect business, results of operation and financial condition.
• If tax laws change or we experience adverse outcomes resulting from examination of our tax returns or disagreements with taxing authorities, it could adversely affect our business, financial condition, and results of operations.
• We may become subject to litigation brought by third parties claiming infringement, misappropriation, or other violation by us of their intellectual property rights.
• Climate change or legal, regulatory or market measures to address climate change may negatively affect our business, results of operations, and financial condition.
• The increasing focus on ESG and sustainability matters or the failure or perceived failure to meet our ESG and sustainability goals may increase our costs, harm our reputation or adversely affect our business.
• We are involved in legal proceedings and disputes, which could adversely impact our business, results of operations, and financial condition.
• Our failure to comply with laws and regulations relating to reimbursement of healthcare goods and services may subject us to penalties and adversely impact our reputation, business, results of operations, financial condition, and cash flows.
• Our insurance program may not cover claims brought against us, deny coverage of claims, or be inadequate to cover future losses.
• Any failure to obtain, maintain, protect and enforce our intellectual property rights, or the failure of the strength or scope of our intellectual property rights, could harm our business, financial condition, and results of operations.
• Risks Related to Financial and Economic Market Conditions
• Foreign currency exchange rate fluctuations could have a significant impact on our results of operations.
• Our profitability and cash flows may be adversely affected by inflationary pressures.
• Uncertain global and domestic macro-economic and political conditions could materially adversely affect our business, results of operations, and financial condition.
• Our manufacturing business is exposed to price fluctuations of key commodities, which may negatively impact our results of operations and cash flows.
• Risks Related to Our Indebtedness
• Our substantial indebtedness could adversely affect our financial condition, our ability to operate our business or react to changes in the economy or our industry, prevent us from fulfilling our obligations under our debts, and divert our cash flow from operations for debt payments.
• The credit agreement that governs the Senior Secured Credit Facilities and the indentures that govern the Senior Notes will each impose significant operating and financial restrictions on our subsidiaries, which may prevent us from capitalizing on business opportunities.
• Risks Related to Our Organizational Structure
• Medline Inc. is a holding company and its only material assets are its equity interests held directly or indirectly through wholly owned subsidiaries in Medline Holdings, and it is accordingly dependent upon distributions from Medline Holdings to pay taxes, make payments under the tax receivable agreement, and pay any dividends.
• Our tax receivable agreement confers benefits upon certain of our pre-IPO owners.
• In certain cases, payments under the tax receivable agreement may significantly exceed the actual benefits Medline Inc. realizes in respect of the tax attributes subject to the tax receivable agreement.
• The application of certain valuation assumptions under the tax receivable agreement in the case of certain changes of control or other events may impair our ability to consummate change of control transactions or negatively impact the value received by owners of our Class A common stock.
• Risks Related to Ownership of our Class A Common Stock
• The Designating Stockholders hold a significant percentage of our stock, and their interests may conflict with ours or yours in the future.
• Our amended and restated certificate of incorporation does not limit the ability of our Sponsors, the Mills family, and certain other pre-IPO investors to compete with us, and they may have investments in businesses whose interests conflict with ours.
• We will incur increased costs and have become subject to additional regulations and requirements as a result of becoming a public company, which could lower our profits, make it more difficult to run our business, or divert management’s attention from our business.
• Failure to comply with requirements to design, implement, and maintain effective internal controls could have a material adverse effect on our business and stock price.
• If securities or industry analysts do not publish research or reports about our business, or if they downgrade their recommendations regarding our Class A common stock, our stock price and trading volume could decline.
• We cannot predict the impact our dual class structure may have on the market price of our Class A common stock.
• The market price of shares of our Class A common stock may be volatile or may decline regardless of our operating performance, which could cause the value of your investment to decline.
• You may be diluted by the future issuance of additional Class A common stock or Common Units in connection with our incentive plans, acquisitions or otherwise.
• We may issue preferred stock whose terms could materially adversely affect the voting power or value of our Class A common stock.
• If we or our pre-IPO owners sell additional shares of our Class A common stock or are perceived by the public markets as intending to sell them, the market price of our Class A common stock could decline.
• Anti-takeover provisions in our organizational documents and Delaware law might discourage or delay acquisition attempts for us that you might consider favorable.
• Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware or the federal district courts of the United States of America, as applicable, as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with the Company or the Company’s directors, officers, or other employees.